CFA
VNDA icon

Carroll Financial Associates’s Vanda Pharmaceuticals VNDA Stock Holding History

Carroll Financial Associates’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-109
Closed -$1K – 1957
2021
Q3 		$1K Buy
+109
New +$1.91K ﹤0.01% 1729

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carroll Financial Associates's VNDA Position: Q4 2021 in Review

Carroll Financial Associates sold out of Vanda Pharmaceuticals (VNDA) in Q4 2021, closing a stake of 109 shares — an estimated $1K sold.

Carroll Financial Associates first reported a position in VNDA in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 198 funds tracked by Wall St. Rank hold VNDA as of Q4 2021.

  • Carroll Financial Associates reported no remaining Vanda Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Carroll Financial Associates sold 109 Vanda Pharmaceuticals shares in Q4 2021, an estimated $1K.
  • Carroll Financial Associates first reported a position in Vanda Pharmaceuticals in Q3 2021 and held it in 1 quarter.
  • Carroll Financial Associates's Vanda Pharmaceuticals position peaked at $1K in Q3 2021.
  • 198 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.